|
1
|
Fish JM, Welchons DR, Kim YS, Lee SH, Ho
WK and Antzelevitch C: Dimethyl lithospermate B, an extract of
Danshen, suppresses arrhythmogenesis associated with the Brugada
syndrome. Circulation. 113:1393–1400. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chang PN, Mao JC, Huang SH, Ning L, Wang
ZJ, On T, Duan W and Zhu YZ: Analysis of cardioprotective effects
using purified Salvia miltiorrhiza extract on isolated rat
hearts. J Pharmacol Sci. 101:245–249. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Che AJ, Zhang JY, Li CH, Chen XF, Hu ZD
and Chen XG: Separation and determination of active components in
Radix Salviae miltiorrhizae and its medicinal preparations by
nonaqueous capillary electrophoresis. J Sep Sci. 27:569–575. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhou L, Zuo Z and Chow MS: Danshen: An
overview of its chemistry, pharmacology, pharmacokinetics and
clinical use. J Clin Pharmacol. 45:1345–1359. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Adams JD, Wang R, Yang J and Lien EJ:
Preclinical and clinical examinations of Salvia miltiorrhiza
and its tanshinones in ischemic conditions. Chin Med. 1:32006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cheng TO: Cardiovascular effects of
Danshen. Int J Cardiol. 121:9–22. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gao J, Yang G, Pi R, Li R, Wang P, Zhang
H, Le K, Chen S and Liu P: Tanshinone IIA protects neonatal rat
cardiomyocytes from adriamycin-induced apoptosis. Transl Res.
151:79–87. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang L, Zou X, Liang Q, Chen H, Feng J,
Yan L, Wang Z, Zhou D, Li S, Yao S and Zheng Z: Sodium tanshinone
IIA sulfonate depresses angiotensin II-induced cardiomyocyte
hypertrophy through MEK/ERK pathway. Exp Mol Med. 39:65–73. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang R, Liu A, Ma X, Li L, Su D and Liu J:
Sodium tanshinone IIA sulfonate protects cardiomyocytes against
oxidative stress-mediated apoptosis through inhibiting JNK
activation. J Cardiovasc Pharmacol. 51:396–401. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shanghai Cooperative Group for the Study
of Tanshinone IIA: Therapeutic effect of sodium tanshinone IIA
sulfonate in patients with coronary heart disease. A double blind
study. J Tradit Chin Med. 4:20–24. 1984.PubMed/NCBI
|
|
11
|
Bartel DP: Micrornas: Genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jackson RJ and Standart N: How do
microRNAs regulate gene expression? Sci STKE. 2007:re12007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Roy S, Khanna S, Hussain SR, Biswas S,
Azad A, Rink C, Gnyawali S, Shilo S, Nuovo GJ and Sen CK: MicroRNA
expression in response to murine myocardial infarction: Mir-21
regulates fibroblast metalloprotease-2 via phosphatase and tensin
homologue. Cardiovasc Res. 82:21–29. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
van Rooij E, Sutherland LB, Thatcher JE,
DiMaio JM, Naseem RH, Marshall WS, Hill JA and Olson EN:
Dysregulation of microRNAs after myocardial infarction reveals a
role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA.
105:13027–13032. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shan H, Zhang Y, Lu Y, Zhang Y, Pan Z, Cai
B, Wang N, Li X, Feng T, Hong Y and Yang B: Downregulation of
miR-133 and miR-590 contributes to nicotine-induced atrial
remodelling in canines. Cardiovasc Res. 83:465–472. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang L, Wu Y, Li Y, Xu C, Li X, Zhu D,
Zhang Y, Xing S, Wang H, Zhang Z and Shan H: Tanshinone IIa
improves miR-133 expression through MAPK ERK1/2 pathway in hypoxic
cardiac myocytes. Cell Physiol Biochem. 30:843–852. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Takaya T, Ono K, Kawamura T, Takanabe R,
Kaichi S, Morimoto T, Wada H, Kita T, Shimatsu A and Hasegawa K:
MicroRNA-1 and microRNA-133 in spontaneous myocardial
differentiation of mouse embryonic stem cells. Circ J.
73:1492–1497. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Matsui T and Rosenzweig A: Convergent
signal transduction pathways controlling cardiomyocyte survival and
function: The role of PI 3-kinase and Akt. J Mol Cell Cardiol.
38:63–71. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Amaravadi R and Thompson CB: The survival
kinases Akt and Pim as potential pharmacological targets. J Clin
Invest. 115:2618–2624. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hescheler J, Meyer R, Plant S, Krautwurst
D, Rosenthal W and Schultz G: Morphological, biochemical and
electrophysiological characterization of a clonal cell (H9c2) line
from rat heart. Circ Res. 69:1476–1486. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hong HJ, Liu JC, Cheng TH and Chan P:
Tanshinone IIA attenuates angiotensin II-induced apoptosis via Akt
pathway in neonatal rat cardiomyocytes. Acta Pharmacol Sin.
31:1569–1575. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang MQ, Zheng YL, Chen H, Tu JF, Shen Y,
Guo JP, Yang XH, Yuan SR, Chen LZ, Chai JJ, et al: Sodium
tanshinone IIA sulfonate protects rat myocardium against
ischemia-reperfusion injury via activation of PI3K/Akt/FOXO3A/Bim
pathway. Acta Pharmacol Sin. 34:1386–1396. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wei B, Li WW, Ji J, Hu QH and Ji H: The
cardioprotective effect of sodium tanshinone IIA sulfonate and the
optimizing of therapeutic time window in myocardial
ischemia/reperfusion injury in rats. Atherosclerosis. 235:318–327.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu WY, Wang WY, Ma YL, Yan H, Wang XB, Qin
YL, Su M, Chen T and Wang YP: Sodium tanshinone IIA silate inhibits
oxygen-glucose deprivation/recovery-induced cardiomyocyte apoptosis
via suppression of the NF-κb/TNF-α pathway. Br J Pharmacol.
169:1058–1071. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang B, Shravah J, Luo H, Raedschelders K,
Chen DD and Ansley DM: Propofol protects against hydrogen
peroxide-induced injury in cardiac H9c2 cells via Akt activation
and Bcl-2 up-regulation. Biochem Biophys Res Commun. 389:105–111.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun DD, Wang HC, Wang XB, Luo Y, Jin ZX,
Li ZC, Li GR and Dong MQ: Tanshinone IIA: A new activator of human
cardiac KCNQ1/KCNE1 (I(Ks)) potassium channels. Eur J Pharmacol.
590:317–321. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shang Q, Xu H and Huang L: Tanshinone IIA:
A promising natural cardioprotective agent. Evid Based Complement
Alternat Med. 2012:7164592012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gao S, Liu Z, Li H, Little PJ, Liu P and
Xu S: Cardiovascular actions and therapeutic potential of
tanshinone IIA. Atherosclerosis. 220:3–10. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tong Y, Xu W, Han H, Chen Y, Yang J, Qiao
H, Hong D, Wu Y and Zhou C: Tanshinone IIA increases recruitment of
bone marrow mesenchymal stem cells to infarct region via
up-regulating stromal cell-derived factor-1/CXC chemokine receptor
4 axis in a myocardial ischemia model. Phytomedicine. 18:443–450.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yuan X, Jing S, Wu L, Chen L and Fang J:
Pharmacological postconditioning with tanshinone IIA attenuates
myocardial ischemia-reperfusion injury in rats by activating the
phosphatidylinositol 3-kinase pathway. Exp Ther Med. 8:973–977.
2014.PubMed/NCBI
|
|
31
|
Song W, Pu J and He B: Tanshinol protects
human umbilical vein endothelial cells against hydrogen
peroxide-induced apoptosis. Mol Med Rep. 10:2764–2770.
2014.PubMed/NCBI
|
|
32
|
Zhao Y, Samal E and Srivastava D: Serum
response factor regulates a muscle-specific microRNA that targets
Hand2 during cardiogenesis. Nature. 436:214–220. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B,
Zhang Y, Xu C, Bai Y, Wang H, et al: The muscle-specific microRNA
miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1
and KCNJ2. Nat Med. 13:486–491. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Carè A, Catalucci D, Felicetti F, Bonci D,
Addario A, Gallo P, Bang ML, Segnalini P, Gu Y, Dalton ND, et al:
MicroRNA-133 controls cardiac hypertrophy. Nat Med. 13:613–618.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dong DL, Chen C, Huo R, Wang N, Li Z, Tu
YJ, Hu JT, Chu X, Huang W and Yang BF: Reciprocal repression
between microRNA-133 and calcineurin regulates cardiac hypertrophy:
A novel mechanism for progressive cardiac hypertrophy.
Hypertension. 55:946–952. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
He B, Xiao J, Ren AJ, Zhang YF, Zhang H,
Chen M, Xie B, Gao XG and Wang YW: Role of miR-1 and miR-133a in
myocardial ischemic postconditioning. J Biomed Sci. 18:222011.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hausenloy DJ and Yellon DM: Reperfusion
injury salvage kinase signalling: Taking a risk for
cardioprotection. Heart Fail Rev. 12:217–234. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Matsui T, Tao J, del Monte F, Lee KH, Li
L, Picard M, Force TL, Franke TF, Hajjar RJ and Rosenzweig A: Akt
activation preserves cardiac function and prevents injury after
transient cardiac ischemia in vivo. Circulation. 104:330–335. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gustin JA, Korgaonkar CK, Pincheira R, Li
Q and Donner DB: Akt regulates basal and induced processing of
NF-kappaB2 (p100) to p52. J Biol Chem. 281:16473–16481. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Luo JL, Kamata H and Karin M: The
anti-death machinery in IKK/NF-kappaB signaling. J Clin Immunol.
25:541–550. 2005. View Article : Google Scholar : PubMed/NCBI
|
